Ir para o conteúdo principal

Infelizmente, não oferecemos suporte total ao seu navegador. Se for possível, atualize para uma versão mais recente ou use o Mozilla Firefox, o Microsoft Edge, o Google Chrome ou o Safari 14 ou mais recente. Se não conseguir e precisar de suporte, envie seu feedback.

Gostaríamos de receber seu feedback sobre essa nova experiência.Diga-nos sua opinião abre em uma nova guia/janela

Elsevier
Publique conosco

Translational Epigenetics

Aim & scope

Translational Epigenetics is a major new series of print and ebooks in biomedical research reference literature. The series reviews advances in epigenetics and epigenomics, with an emphasis on clinical opportunity.

The area of Translational Epigenetics deserves special consideration in what is otherwise a component of biological science because the origins of health and susceptibility to disease may in part be attributed to “epigenesis,” the differentiation programs that orchestrate when and where genes and their products are expressed within the genetic blueprint.

translational-epigenetics-header-banner

Many varied and complex molecular processes contribute to these programs, with products including transcription factors, chromatin regulators, DNA methylation, histone modifications, and RNAs. Epigenetic mechanisms that control stem cell differentiation and organogenesis may also contribute to the biological response to endogenous and exogenous forms of stimuli that result in disease.

Written and edited by leading researchers, the series is primarily intended for researchers in genomics, epigenetics, and related biomedical disciplines at the graduate level and above.

Audience

Primary Market/Audience:

  • Active researchers in genomics, epigenetics, molecular biology, cell biology, and developmental biology

  • Clinician scientists exploring translational applications of epigenetics in clinical settings

Secondary Market/Audience:

  • Graduate and postgraduate students in genomics, epigenetics, and related biomedical fields

  • Educators and academic faculty

  • Healthcare professionals interested in epigenetic diagnostics and therapies

  • Pharmaceutical and biotechnology industry professionals involved in drug discovery and development

  • Public health researchers focusing on disease susceptibility and prevention

Series Editor

TT

Trygve Tollefsbol

Distinguished Professor of Biology and Senior Scientist

University of Alabama at Birmingham

Ler mais sobre Trygve Tollefsbol

Translational Epigenetics

translational-epigenetics-volume-banner